Tokyo, Sept. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061988) titled 'High-flow nasal cannula versus noninvasive positive pressure ventilation for pulsed field ablation with deep sedation' on Sept. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Toyama Prefectural Central Hospital,
Condition:
Condition - atrial fibrillation
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - we conducted a prospective observational study comparing the safety and efficacy of NHF and NIV during PFA
Basic objectives2 - Safety
Eligibility:
Age-lower limit - 20
years-old
=
Gender - Male and Female
Key inclusion criteria - Consecutive patients who underwent catheter ablation for atrial fibrillation between April 2025 to march 2027
Key exclusion criteria - Patients on renal replacement therapy or those with an eGFR < 30 mL/min/1.73 m2 were excluded. Exclusion criteria also included anaphylaxis, cardiogenic shock, and cases in which intraoperative monitoring of SpO2 or non-invasive blood pressure could not be reliably performed.
Target Size - 280
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 04 Month 30 Day
Date of IRB - 2026 Year 01 Month 28 Day
Anticipated trial start date - 2025 Year 05 Month 01 Day
Last follow-up date - 2026 Year 05 Month 01 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068907
Disclaimer: Curated by HT Syndication.
